Medicare Benefits Schedule - Note TN.8.209

• Histological proof of either the benign, the aggressive benign, or the malignant nature of the process should be obtained.
• Histological proof may be obtained in conjunction with items 50203, 50206 or 50209. It may be obtained at the time of the procedure (e.g. by intraoperative frozen section analysis of the tumour tissue).

Related Items: 50200 50201 50203 50206 50209

• Previous - Note TN.8.208
• Next - Note TN.8.210

Multiple Operation Rule

Core needle biopsy of aggressive or potentially malignant bone or soft tissue tumour, excluding aftercare  

(Anaes.)

Fee: $214.40 Benefit: 75% = $160.80 85% = $182.25

(See para TN.8.209 of explanatory notes to this Category)

Multiple Operation Rule

Incisional biopsy of aggressive or potentially malignant bone or soft tissue tumour, excluding aftercare

(Anaes.) (Assist.)

Fee: $375.35 Benefit: 75% = $281.55 85% = $319.05

(See para TN.8.209 of explanatory notes to this Category)

Multiple Operation Rule

Intralesional or marginal excision of bone or soft tissue tumour (H)

(Anaes.) (Assist.)

Fee: $471.90 Benefit: 75% = $353.95

(See para TN.8.171, TN.8.209 of explanatory notes to this Category)

Multiple Operation Rule

Intralesional or marginal excision of bone tumour, with at least one of the following:

(a) autograft;

(b) allograft;

(c) cementation

(H)

(Anaes.) (Assist.)

Fee: $697.20 Benefit: 75% = $522.90

(See para TN.8.171, TN.8.209 of explanatory notes to this Category)

Multiple Operation Rule

Intralesional or marginal excision of bone tumour, with at least 2 of the following:

(a) autograft;

(b) allograft;

(c) cementation

(H)

(Anaes.) (Assist.)

Fee: $858.10 Benefit: 75% = $643.60

(See para TN.8.171, TN.8.209 of explanatory notes to this Category)